Emergent BioSolutions Inc.

EBS

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001196632-26-000011
Filing date: Mar 6, 2026
Earliest execution date: May 7, 2025
Reporting Owners: LINDAHL RICHARD S (CFO)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Employee Stock Option (Right to buy)

Action

Sell

Date

2025-05-07

Code

H

Net shares

-19,963.0

Acquired/Disposed

Disposed

Shares Owned Before

19,963.0

Shares Owned After

0.0

Transaction 2

Security

Employee Stock Option (Right to buy)

Action

Sell

Date

2026-02-25

Code

H

Net shares

-20,321.0

Acquired/Disposed

Disposed

Shares Owned Before

20,321.0

Shares Owned After

0.0

Filing's footnotes

1. The reported stock options expired unexercised pursuant to their terms and no value was received.

2. Vested in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021.

3. Vested in three equal installments beginning on the day prior to the first anniversary of the date of grant, subject to continued service with the company.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.